The identification of reliable diagnostic and prognostic biomarkers is crucial for improving early detection and guiding personalized treatment of mesothelioma, an aggressive cancer with a poor prognosis. While current approaches to mesothelioma diagnosis and monitoring are limited, recent research has highlighted the potential of long noncoding RNAs (lncRNAs) as a novel class of blood-based biomarkers that could revolutionize mesothelioma management. LncRNAs have emerged as promising biomarkers due to their unique expression patterns in various cancer types.
This webcast will explore the significance and clinical utility of plasma-derived lncRNA biomarkers for mesothelioma. An overview of the latest scientific evidence will highlight the promise of plasma lncRNA biomarkers to transform early detection and treatment monitoring for mesothelioma patients. Identifying these innovative clinical tools could lead to improved outcomes and quality of life for those affected by this devastating disease.
You will learn:
• The emerging role of lncRNAs as cancer biomarkers and their detection in liquid biopsies
• Studies demonstrating the diagnostic accuracy and prognostic value of specific plasma lncRNA signatures in mesothelioma
• Technological advancements enabling sensitive and specific detection of lncRNAs in plasma
Unable to join the live event? Watch on demand. Register now to ensure that you receive information on how to gain access after the live event.
This webcast has been produced by Thermo Fisher Scientific who retains sole responsibility for content. About this content.
Speaker
Manar Mansour, Assistant Professor, The German University in Cairo
Manar Mansour, PhD, is an Assistant Professor and Research Group Leader in the Department of Molecular Biology and Microbiology, Faculty of Pharmacy and Biotechnology, at The German University in Cairo. During her journey as a researcher, Dr. Mansour characterized a novel gene that functions as a cytoplasmic biosensor of light and oxygen in the bacterium Rhodospirillum rubrum. In addition to her research on bacterial signalling pathways, Dr. Mansour has also investigated the potential of using Salmonella bacteria as a delivery vector for anti-tumor proteins and peptides in cancer gene therapy approaches. Currently, her research predominantly focuses on the field of diagnostic and prognostic biomarkers in cancer, with a particular emphasis on mesothelioma, a rare and aggressive form of cancer.
Moderator
Nikki Forrester, Freelance Science Writer and Editor
Nikki Forrester is a science journalist who covers biology, natural history, climate, and the culture of academic research. She earned a Ph.D. in ecology and evolutionary biology in 2019.
